Myocardial rupture

From WikEM
Jump to: navigation, search

Background

  • Rupture includes defects in the atria, ventricles, or junctions of major vessels

Etiology

  • Myocardial infarction – “Softening” of myocardium[1]
    • 1.7% of MI patients
    • Typically occurs 24-48h post-MI (can be 3-5d if MI was untreated)
    • Rupture in the setting of MI is nearly 100% fatal[2]
  • Trauma – blunt and penetrating trauma
    • Penetrating trauma tends to affect RV
    • RV 43%, LV 23%, RA 13%, LA 11%, Pericardium alone 10%[3]
  • Infection – Endocarditis and myocardial necrosis[4]
    • Rare
  • Iatrogenic – Pacer wire placement[5]
    • Tend to be small perforations which rarely lead to tamponade or hemodynamic consequences

Clinical Features

  • Chest pain, shortness of breath
  • Obvious chest injury
  • Hypotension
  • JVD
  • Muffled heart sounds or new murmur or rub

Differential Diagnosis

Chest pain

Critical

Emergent

Nonemergent

Workup

  • Ultrasound
    • Pericardial effusion
    • Tamponade physiology (e.g. RV diastolic collapse)
    • Doppler interrogation across the mitral valve will demonstrate exaggerated respiratory variability of transvalvular flow (due to the phenomenon of ventricular interdependence)
  • ECG
    • Tachycardia (bradycardia is ominous finding)
    • Normal or low voltage
    • Electrical alternans, low voltage QRS
  • CXR
    • Enlarged cardiac silhouette
  • Pulsus Paradoxus
    • >10mmHg change in systolic BP on inspiration
  • Direct visualization on thoracotomy (if indicated)

Management

  • Pericardiocentesis in cases of tamponade
  • Thoracotomy in traumatic cases
    • Penetrating chest trauma with signs of life in the field
    • Blunt chest trauma with signs of life lost in ED
  • Definite treatment is emergency surgical repair

Disposition

  • Admit (likely directly to OR with cardiothoracic surgery)

See Also

External Links

References

  1. ↑ Beck RC, et al. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists. Thrombolysis. 1999; 33(2):479-487.
  2. ↑ Beck RC, et al. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists. Thrombolysis. 1999; 33(2):479-487.
  3. ↑ Jin-mou Gao MD, et al. Penetrating cardiac wounds: Principles for surgical management. World Journal of Surgery. 2004; 28(10)1025-1029.
  4. ↑ Qizilbash AH and Schwartz CJ. False aneurysm of left ventricle due to perforation of mitral-aortic intervalvular fibrosa with rupture and cardiac tamponade: Rare complication of infective endocarditis. 1973; 32(1) :110-113.
  5. ↑ Trigano JA, et al. Heart perforation following transvenous implantation of a cardiac pacemaker. Presse Med. 1999; 28:836–40.